Stay updated on Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.

Latest updates to the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; there are no visible changes to the study details, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded gastric cancer as a condition and introduced the Genetic and Rare Diseases Information Center as a resources link; updated the page revision to v3.4.2 and removed the government funding status notice.SummaryDifference0.6%

- Check49 days agoChange DetectedA site-wide notice about a lapse in government funding was added, directing users to cc.nih.gov and opm.gov for status updates. The page revision label was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check56 days agoChange DetectedAdded a Show glossary toggle and updated metadata labels to reflect the latest QC status and version (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4 on the page, a minor change not affecting trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vactosertib With Pembrolizumab in Colorectal/Gastric Cancer Clinical Trial page.